Bicycle Therapeutics (BCYC) Cash from Financing Activities: 2018-2025
Historic Cash from Financing Activities for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to -$30,000.
- Bicycle Therapeutics' Cash from Financing Activities rose 99.91% to -$30,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $87,000, marking a year-over-year decrease of 99.98%. This contributed to the annual value of $519.8 million for FY2024, which is 107.88% up from last year.
- Per Bicycle Therapeutics' latest filing, its Cash from Financing Activities stood at -$30,000 for Q3 2025, which was up 33.33% from -$45,000 recorded in Q2 2025.
- Over the past 5 years, Bicycle Therapeutics' Cash from Financing Activities peaked at $549.6 million during Q2 2024, and registered a low of -$31.9 million during Q3 2024.
- Over the past 3 years, Bicycle Therapeutics' median Cash from Financing Activities value was $386,000 (recorded in 2023), while the average stood at $70.0 million.
- In the last 5 years, Bicycle Therapeutics' Cash from Financing Activities surged by 3,702,850.00% in 2021 and then tumbled by 113.61% in 2024.
- Quarterly analysis of 5 years shows Bicycle Therapeutics' Cash from Financing Activities stood at $190.7 million in 2021, then plummeted by 96.91% to $5.9 million in 2022, then slumped by 93.44% to $386,000 in 2023, then tumbled by 47.41% to $203,000 in 2024, then spiked by 99.91% to -$30,000 in 2025.
- Its Cash from Financing Activities was -$30,000 in Q3 2025, compared to -$45,000 in Q2 2025 and -$41,000 in Q1 2025.